MINUTES. Meeting Name: Pharmacy Forum Date: 14 th September 2012 Venue: Halton Stadium, Lower House Lane, Widnes, Cheshire, WA8 7DZ
|
|
- Claud Neal
- 5 years ago
- Views:
Transcription
1 Meeting Name: Pharmacy Forum Date: 14 th 2012 Venue: Halton Stadium, Lower House Lane, Widnes, Cheshire, WA8 7DZ In Attendance: Jo Bateman (Chair), Countess of Chester Hospital () Diane Hornsby, (Secretary) NHS Western Cheshire (DH) Anne Henshaw, Knowsley Shadow CCG (AH) Caroline Bagley, Southport and Ormskirk Hospital NHS Trust (CB) Dave Thornton, Aintree Hospital (DT) Nicola Baxter, NHS Central Lancashire PCT (NB) Mina McFaul, North Cheshire Hospitals NHS Trust (MM) Jenny Lunn, Warrington Health Consortium (JL) Anu Brough, Liverpool PCT (AB) Cassandra Edgar, St Helens and Knowsley NHS Trust (CE) Rebecca Curran, Wirral University Teaching Hospital (RC) Anne Porter, CMCN (AP) Erika Baker, NHS Merseyside (EB) Apologies Danny Forrest, Liverpool Heart and Chest Hospital (DF) Sarah Roden, NHS Western Cheshire (SR) Catherine Lee, Royal Liverpool Hospital (CL) Judith Green, NHS Wirral (JG) Michael Lloyd, St Helens and Knowsley NHS Trust (ML) Jane Eyres, Sefton PCT (JE) Page 1 of 6
2 Agenda Item Notes/Action points Lead Actions AP to finalise draft minutes from 15 th June 2012 and send out to Pharmacy Forum members and store on CMCN website to DF re the fact that several versions of PPCI protocol seemed to be available, and to ask him to send what is required for the final updated document to AP for incorporation into her document. pharmacists (who have not already done so) to forward TTR measurement information through to. RC to circulate palliative care heart failure guidelines to the Pharmacy Forum once approved. to forward information from the Company making Digifab, re using Digifab and Digibind together. to ask Dr Somauroo to draw up some guidance regarding use of bendroflumethiazide in place of metolozone, for use in the area. Pharmacists to send information regarding CCG structure/commissioners to, even if the information is temporary. EB to forward the Omacor recommendation to, who will To be completed by ASAP (latest 25 th Sept) As soon as available Mid October October take it to the Network Board meeting 1. Budget impact of eplerenone in Heart failure A presentation was given by Ivan Beard, Pfizer. Karen O Grady, Pfizer, was also present 2. Minutes from 15 th June The minutes from the previous meeting were approved AP to finalise and send out to Pharmacy Forum members and store on CMCN website AP /DF RC EB/ AP 3. Matters arising from 9 th March 2012 There were no matters arising 4. NSTEACS and PPCI guidance updates/ticagrelor AP stated that there had been a Cardiac Advisory Board (CAB) meeting on 13/9/12 where the NSTEACs guidelines had been discussed and amendments made. The updated guidelines were due to be published on 22 nd Page 2 of 6 AH asked who would be responsible for renal function testing at 30 days after starting ticagrelor, and how the requirement would be communicated to clinicians. DH stated that DF had advised her that at LHCH he was in the
3 process of making it a default on the electronic system and that the responsibility would lie with GPs. A baseline U&E would be provided. There was discussion around the need to ensure that all initiating centres provided this baseline U&E measurement to Primary Care, and for the need to ensure that the discharge letter was received in time for the 30 day test to be performed. It was agreed that this information needed to go on the electronic transfer, to avoid any delays in communication. MM stated that at Warrington Hospital, an automatic pop-up box came up on the system if ticagrelor was prescribed. This had a standard sentence regarding the need for a 30 day renal function test and a space to enter the baseline U&E values. The group agreed that this seemed like a good system. DT requested that it was minuted that the Pharmacy Team at the Secondary or Tertiary Care Centre where ticagrelor was initiated, should not be held responsible for communicating this information to Primary Care. It was noted that the PPCI transfer sheet still stated prasugrel rather than ticagrelor. The group felt that DF would be updating this. However, AP stated that she in fact held this document and she had not been asked to amend it. The fact that several versions of this form may be in circulation was also raised. RC queried if prasugrel had been taken off Formulary yet in other Secondary Care centres. There was a mixed picture within the group, with some Centres not using prasugrel and some Centres keeping it on Formulary until the Network Pathways were released. It was noted that education around ticagrelor was required for Secondary Care doctors. The group discussed the fact that if a patient can t have aspirin, then they should be given clopidogrel rather than ticagrelor, as ticagrelor not licensed as single therapy. It was also noted that there is currently no evidence to support triple therapy, e.g. warfarin, aspirin and ticagrelor. asked if the ticagrelor information sheet was also going to be published on 22 nd Sept. AP said that as far as she was aware it was. stated that some changes had been made to the patient information leaflet, and it was important to ensure that these had been included. to DF re the fact that several versions of PPCI protocol seemed to be available and to ask him to send what is required for the final updated document to AP for incorporation into her document. 5. TTR measurement update stated that she had only had 2 responses to her request at the last meeting for information regarding which areas have TTR routinely reported for each patient. She requested again that this information be sent through to her. MM stated that Warrington Hospital can t measure TTRs at all. pharmacists (who have not already done so) to forward TTR measurement information through to. Page 3 of 6
4 6. NOAC update DT updated the group, saying that rivaroxaban and dabigatran position statements had been released. An agreed bleeding protocol was still needed. DT stated that some Haematologists were not happy to have blood products on the bleeding protocol, as they were expensive, didn t work and possibly were pro-coagulant, so increasing the risk of stroke. DT said that he had drawn up a protocol for Aintree Hospital, based on the protocol from Barts, but without the blood products on it, and with a statement to contact Haematology in the case of a bleed. Discussions around the table highlighted the fact that bleeding protocols were being discussed in all areas, but there was little consensus. RC agreed to forward the Wirral s bleeding protocol to the Forum once it had been approved. stated that she would start working on the patient information leaflet again, as the one coming from NICE had been delayed further. DT stated that TTR and warfarin instability monitoring would be discussed at the next AF Task Group meeting, scheduled for 27 th. He said that education was needed around what TTR was and how it was calculated. DH queried the reference to TTR <67% with warfarin as the point at which rivaroxaban treatment might be considered, in the Network Rivaroxaban Position Statement. DT stated that this figure was different to the one in the rivaroxaban (ROCKET) study, but that it had been decided to stay with 67% as for dabigatran. It was agreed that the first choice NOAC should be dabigatran, rather than rivaroxaban. 7. Stable angina guidelines AP stated that the update to these had been agreed and that they would be published on 22 nd. 8. Palliative Care Heart Failure Guidelines RC stated that she had requested the whole document to be rewritten, as it had escalated to 65 pages. It is expected that it will be published towards the end of. RC will circulate it to the Forum when it has been approved. RC to circulate palliative care heart failure guidelines to the Pharmacy Forum once approved RC 9. Digifab This item followed discussion at the last meeting regarding the possibility of keeping a centrally located stock of Digifab. told the group that the College of Emergency Medicine s document stated that each hospital must hold 10 vials of antidote in stock and that this must be available within 1 hour of needing it. In theory, up to 20 vials might be needed. It was also noted that the central location would have to be a hospital with a Residency, and this only applied to Arrowe Park hospital. The Forum felt that it would be unfair to expect APH to always be the central stock holder and so it was concluded that each hospital would need to keep their own supply of Digifab. stated that the company making Digifab had issued guidance re how to use Digifab and Digibind together. Page 4 of 6
5 to forward info re using Digifab and Digibind together 10. Metolozone The discontinuation of this product had not been discussed at CAB. The consensus within the Pharmacy Forum was that bendroflumethiazide should be used instead, although it was noted that no specific guidelines regarding this existed. to ask Dr Somauroo to draw up some guidance regarding use of bendroflumethiazide in place of metolozone, for use in the area 11. Commissioners said that there had been little response to her request at the last meeting for information regarding who the Commissioners were now in each area. stated that specific names were needed, so that the Cardiac Network could communicate and work effectively. Pharmacists to send information regarding CCG structure/ Commissioners to, even if the information is temporary 12. Omacor post MI EB stated that she was working on a document whereby Omacor, as secondary prevention of MI, would not be prescribed in Secondary Care, but instead would be prescribed by the patient s GP, who could assess lifestyle issues. EB requested that the Cardiac Network agree with this position. There was a lot of discussion around this, and it was noted that at CAB, all of the Consultants had stated that it was important to prescribe Omacor and wanted to continue to do so. RC stated that if Omacor was to be stopped or not prescribed, then it was important to ensure that Omacor was not being recommended for patients with heart failure or arrhythmias. EB to forward the Omacor recommendation to, who will take it to the Network Board meeting for consideration 13. Presentation for November meeting It was agreed that the next presentation should be on rivaroxaban in acute coronary syndrome. EB AP 14. A.O.B. CMCN statin guidelines. This had been discussed at CAB and it had been agreed that new guidance from NICE (due 2013) should be published before a sub-group was set up to look at this. Page 5 of 6 New data regarding drug interactions for simvastatin. There was no definite consensus within the group regarding what to do w.r.t. the new data showing an increased risk of myopathy and/or rhabdomyolysis when simvastatin is given with various drugs (MHRA Drug safety Update Aug 2012). With respect to the specific interaction between simvastatin and
6 amlodipine. The two main options discussed involved either reducing the dose of simvastatin to 20mg, or switching simvastatin to atorvastatin (no agreement on dose). Representation at CAB. EB stated that there should be a representative from the Pharmacy Forum attending the CAB meetings. At the least, the Forum should receive a copy of the agenda for each CAB meeting. stated that due to the number of other meetings she already attends, she could not commit to attending the CAB meetings as well. However, if the Network Board felt that a Pharmacy Forum representative was appropriate, then this could be discussed within the Forum Date & Time of next meeting: TH November 2012 Page 6 of 6
PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) PROTOCOL
PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) PROTOCOL EXTRACT FOR USE BY NORTH WEST AMBULANCE SERVICE PARAMEDICS Revised April 2013 Liverpool Heart and Chest Hospital Aintree University Hospital Countess
More informationStroke Services Cheshire & Merseyside
PRESENTATION TITLE Stroke Services Cheshire & Merseyside Dr Deborah Lowe Consultant Stroke Physician SCN Clinical Lead for Stroke Why are we here? We all want to deliver high quality stroke care to our
More informationSetting up the NOAC Service & Taking it to Primary Care
Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side
More informationCheshire & Merseyside Sustainability and Transformation Plan. People and Services Fit for the Future
Cheshire & Merseyside Sustainability and Transformation Plan People and Services Fit for the Future 2 The Challenge for the NHS As a nation we are fortunate to have a National Health Service that is free
More informationSouth East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes
South East London Area Prescribing Committee (APC) 9 October at Lower Marsh Final minutes 1. Welcome, Introductions and Apologies received. 2. Conflicts of Interest declarations The Chair requested any
More informationPOWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE
POWYS TEACHING HEALTH BOARD Meeting 04/12/12 Present: PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE Minutes of the meeting held on Thursday, 06 September 2012 at 09.30am in Training Room 1, Bronllys
More informationNorth West COPD Report Nov 2011
North West COPD Report Nov 2011 Working together to improve respiratory care in the North West 1 Contents Introduction foreword by NW Respiratory Leads... 3 4 reasons why COPD is important in the North
More informationChester City and Rural Prescribing Leads Meeting Wednesday 1 st October 2014 Room A 1829 building
Chester City and Rural Prescribing Leads Meeting Wednesday 1 st October 2014 Room A 1829 building Dr Andy Dunbavand () (chair) Dr L Davies (LD) Dr A Ojeda (AO) Dr C Fryar (CF) Dr P Davis (PD) Dr R Brooks
More informationUKMi Conference 2011 Structural Changes in the NHS Vic Standing Pharmaceutical Adviser NHS NW. Healthier Horizons
UKMi Conference 2011 Structural Changes in the NHS Vic Standing Pharmaceutical Adviser NHS NW Healthier Horizons 1988 Secretary of State For Health Department of Health Special Health Authorities (8) NHS
More informationNPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
More informationWest Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care
West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care Good Practice Guide Improving the detection and management of Atrial Fibrillation
More informationClinical pharmacists in general practice links with community pharmacy
Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.
More informationRising to the challenge: Delivering QIPP by preventing AF-related stroke. Foreword
2 Foreword Rising to the challenge: Delivering QIPP by preventing AF-related stroke Opportunities to improve the quality, safety and cost-effectiveness of NHS services that reduce the risk of stroke in
More informationAHSN AF Programme The Results So Far. Kate Mackay AF Programme Manager
AHSN AF Programme The Results So Far Kate Mackay AF Programme Manager Atrial Fibrillation Programme Aim To decrease the number of AF-related strokes by: Decreasing the prevalence gap and finding the missing
More informationReview of the Heart Failure Service
Review of the Heart Failure Service September 2010 Cheshire and Merseyside Cardiac and Stroke Networks Working to improve the delivery of services for cardiac and stroke patients and their families across
More informationQUALITY IMPROVEMENT COMMITTEE
: 2016-002.a QUALITY IMPROVEMENT COMMITTEE Minutes of the meeting held on 11 th February 2016, Conference Room D, 1829 Building Present: Faulkner, Sarah (SF) (Chair) Lay Member, NHS West Cheshire CCG Cavanagh,
More informationClatterbridge Cancer Centre: Transforming Cancer Care in Merseyside and Cheshire Dr. Peter Kirkbride, Medical Director
5 November 2016 Clatterbridge Cancer Centre: Transforming Cancer Care in Merseyside and Cheshire Dr. Peter Kirkbride, Medical Director What we do Systemic anti-cancer therapy e.g. chemotherapy, immunotherapy
More informationMINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING
MINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING Date & Time of Meeting: Venue: Wednesday 8 th February 2012 @ 1.30pm Boardroom, Glangwili Hospital, Carmarthen Present: In Attendance: Dr. Carol Llewellyn-Jones,
More informationSwitch protocol: Brands to generic equivalent
Switch protocol: Brands to generic equivalent Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for
More informationLondon Cardiac & Vascular Strategic Clinical Leadership Group (SCLG) Minutes
London Cardiac & Vascular Strategic Clinical Leadership Group (SCLG) Minutes 7 July 2015 Burfoot Court Room, Guys Hospital, Great Maze Pond, London, SE1 9RT Item 1. Welcome, introductions, apologies In
More informationMinutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 15 May 2013 Room GO2-A, 160 Tooley Street
Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting 2. 00 pm, Wednesday 15 May 2013 Room GO2-A, 160 Tooley Street Present: Dr Catherine Otty (CO) Dr Alan Campion Dr Sian Howell
More informationNHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House.
Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. PRESENT: Dr M Ghani (Chair) Medical Director Barnsley CCG (Designate) Dr
More informationCommissioning effective anticoagulation services for the future: A resource pack for commissioners
Commissioning effective anticoagulation services for the future: A resource pack for commissioners The development of this commissioning toolkit was supported by Bayer HealthCare. Bayer HealthCare paid
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: 3. Key Messages: The paper discussed by the Governing Body on 17 th November 2016 was included as an agenda item for discussion
More informationMinutes of the Lancashire Medicines Management Group Meeting held on Thursday 14 th February 2013 at Preston Business Centre
Minutes of the Lancashire Medicines Management Group Meeting held on Thursday 14 th February 2013 at Preston Business Centre PRESENT: Dr Tony Naughton (TN) Chair NHS Fylde & Wyre CCG Louise Winstanley
More informationPractice Nurse Governing Body Member Governing Body Practice Manager Co-Opted Member. Head of Primary Care Direct Commissioning NHS England
Present: NHS LIVERPOOL CLINICAL COMMISSIONING GROUP PRIMARY CARE COMMISSIONING COMMITTEE Minutes of meeting held on Tuesday 21 ST JUNE 2016 at 10am BOARDROOM, THE DEPARTMENT Voting Members: Dave Antrobus
More informationATRIAL FIBRILLATION & STROKE INSIGHTS TOOL
ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL WORLD/PUBLICALLY AVAILABLE DATA COUPLED WITH TTR DATA HELP THE NHS STOP STROKES? Andrzei Orlowski -Programme Development Lead for Health and Implementation
More informationHospital Pharmacy Transformation Plan
Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &
More informationAdverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN
Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural
More informationSupport for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the
Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the contents of the report to ensure compliance with the ABPI
More informationGOVERNING BODY MEETING in Public 26 September 2018 Agenda Item 1.5
GOVERNING BODY MEETING in Public 26 September 2018 Agenda Item 1.5 Report Title Chief Officers Report Appendix B Cheshire & Merseyside Winter Plans Review Summary Evaluation Cheshire & Merseyside Winter
More informationCommunity DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres
Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment
More informationA Scoping Study on Wellbeing Brief Interventions across Cheshire and Merseyside
A Scoping Study on Wellbeing Brief Interventions across Cheshire and Merseyside Barbara Parratt Commissioned by ChaMPs Public Health Network March 2012 Contents 1. Introduction...3 1.1 Brief Interventions...3
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationClinical Commissioning Group (CCG) Governing Body
Clinical Commissioning Group (CCG) Governing Body Date of Meeting: 20 th July 2012 Agenda Item: Paper 27 Subject: Reporting Officer: GM Clinical Strategy Board Dr Chris Duffy Purpose of the Paper: To provide
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationPrimary Care/Community Based Service Palliative Care (Just in Case Medicines) Fylde and Wyre CCG Pete Smith. Community Pharmacy
Service Specification No. 1. Service Commissioner Lead Provider Lead Primary Care/Community Based Service Palliative Care (Just in Case Medicines) Fylde and Wyre CCG Pete Smith Community Pharmacy Period
More informationQuality Standards Advisory Committee 1. Atrial fibrillation post-consultation meeting
Quality Standards Advisory Committee 1 Atrial fibrillation post-consultation meeting Attendees Minutes of the meeting held on Wednesday 8 th April 2015 at the NICE offices in Manchester Standing Quality
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT Date of Governing Body Meeting: Title of Report: Key Messages: Finance, Performance and Commissioning Committee Report At the end of September 2017 we have reported an inyear deficit
More informationTitle: Replacement of the Commissioning Advisory Forum Agenda Item: 9
Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose
More informationGreater Manchester Cancer
Date of Meeting 21 st September 2016 Time of meeting Venue 9am 12pm Room 6, Trust Administration, The Christie NHS Foundation Trust Attendance Mr Mohammed Absar (Chair) David Makin Anneela Saleem Michael
More informationDigital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT
Digital INR Monitoring A model of remote INR testing Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT About NHS Health Call NHS Health Call is a digital health partnership between
More informationPROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS
STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients
More informationThoracic surgery medicines
Addressograph Name: Date of birth: Hosp No: NHS No: Thoracic surgery medicines A patient s guide Medicine name Date last dose to be taken 1 Introduction This booklet is for patients waiting to have thoracic
More informationPrimary - Secondary Care Interface Management
Primary - Secondary Care Interface Management The Scottish Example Ken Paterson PPRI Conference - Vienna 29 September 2011 NHS Scotland Virtually monopoly payer and provider Universal coverage from general
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting 16 th November 2017 2. Title of Report: 3. Key Messages: BUPA ceased to be the registered provider of Crawfords Walk Nursing Home in October. The
More informationSTRATEGIES TO ACHIEVE COST-EFFECTIVE PRESCRIBING
STRATEGIES TO ACHIEVE COST-EFFECTIVE PRESCRIBING Interim Guidance for Primary Care Trusts STRATEGIES TO ACHIEVE COST- EFFECTIVE PRESCRIBING: Interim Guidance for Primary Care Trusts Prepared by Colin Pearson
More informationThe TTO Journey: How Much Of It Is Actually In Pharmacy?
The TTO Journey: How Much Of It Is Actually In Pharmacy? Green CF 1,2, Hunter L 1, Jones L 1, Morris K 1. 1. Pharmacy Department, Countess of Chester Hospital NHS Foundation Trust. 2. School of Pharmacy
More informationConfirmed Minutes of Regional Transfusion Committee Business Meeting TUESDAY 04 NOVEMBER
Confirmed Minutes of Regional Transfusion Committee Business Meeting TUESDAY 04 NOVEMBER 2014 16.00 18.00 Present: QUEEN ELIZABETH HOSPITAL BIRMINGHAM, POST GRADUATE CONFERENCE CENTRE, BIRMINGHAM B5 2TZ
More informationClinical medication review
CENTRE FOR PHARMACY POSTGRADUATE EDUCATION Clinical medication review A CPPE workshop Workshop book W/MEDREVIEW/HO March 2017 Clinical Medication Review_Workshop Bk A4 24pp.indd 1 15/03/2017 09:13 Clinical
More informationPlease find below the response to your recent Freedom of Information request regarding Continence Services within NHS South Sefton CCG.
Our ref: FOI ID 5544 2 6 th August 2015 southseftonccg.foi@nhs.net NHS South Sefton CCG Merton House Stanley Road Bootle Merseyside L20 3DL Tel: 0151 247 7000 Re: Freedom of Information Request Please
More informationSouth Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting
South Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting Date: 8 th February 2017 Time: 10am-12:30pm Location: The Batch, Warmley, Bristol MINUTES IPEF members
More informationFlexible Sigmoidoscopy with an Enema
Flexible Sigmoidoscopy with an Enema You must read this booklet at least seven days before your test Contents Page What is a flexible sigmoidoscopy? 1 Preparing yourself for a flexible sigmoidoscopy 2
More informationIntegrated heart failure service working across the hospital and the community
Integrated heart failure service working across the hospital and the community Lynne Ruddick Professional Lead (South) British Heart Foundation 31st October 2017 Heart Failure is an epidemic. NICE has
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications 1 Introduction Anticoagulants are medicines which slow down the blood clotting process and are used to support the prevention of clot development. They
More informationConsultation on proposals to introduce independent prescribing by paramedics across the United Kingdom
Patient and public summary for: Consultation on proposals to introduce independent prescribing by paramedics across the United Kingdom The full consultation document is available on the NHS England consultation
More informationINFORMATION FOR PATIENTS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E- mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk INFORMATION
More informationSouth East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions
South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,
More informationDocument ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved
Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation
More informationDelivering the QIPP programme: making existing services improve patient outcomes
Delivering the QIPP programme: making existing services improve patient outcomes Produced by Glyn Davies MP, Chair All-Party Parliamentary Group on AF in association with the Atrial Fibrillation Association
More informationPRESCRIBING SUPPORT TECHNICIAN:
PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin
More informationNote and action points
Note and action points Meeting Blood Pressure System Leadership Board Date 8 December 2015 Time 14:00 16:00 Attendees Jamie Waterall, PHE, NHS Health Check National Lead (Chair) Jenny Hargrave, British
More informationSheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines
Sheffield Teaching Hospitals: Pulmonary Hypertension Information for Medical Staff 31/03/2014 Local guidelines Diagnostic pathway - page 2 Iloprost dosing chart and conversion table - page 3-4 Hickman
More informationVenue: Salford St James House Present: Name Designation Organisation CCG members
GREATER MANCHESTER MEDICINES MANAGEMENT GROUP Minutes Date: Thursday 16 th February 2017 Time: 1pm 3pm Venue: Salford St James House Present: Name Designation Organisation CCG members Dr Helen Burgess
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Chief Executive Officer s Business Report 3. Key Messages: This report provides an overview of important clinical commissioning
More information3. Minutes, action log and attendance list of Last Meeting and Matters Arising. The minutes of the March meeting were accepted as accurate.
South East London Area Prescribing Committee (APC) 23 June 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests, either
More informationAcute kidney injury (quality standard) Stakeholder Abbott GmbH & Co KG AbbVie Aintree University Hospital NHS Foundation Trust Airedale NHS Trust
Acute kidney injury (quality standard) Stakeholder Abbott GmbH & Co KG AbbVie Aintree University Hospital NHS Foundation Trust Airedale NHS Trust Alder Hey Children's NHS Foundation Trust Alere Alere Ltd
More informationHow Pharmacies are supporting the move from Secondary to Primary Care. Peter Bainbridge, Director of Pharmacy,
How Pharmacies are supporting the move from Secondary to Primary Care Peter Bainbridge, Director of Pharmacy, Alliance Boots Present in over 25 countries Over 116,000 employees 3,330 Health and Beauty
More informationSusan Convery, Business Support Assistant, NESCN
Meeting: Heart Disease Clinical Advisory Group Business Meeting Date: 23 March 2016 Time: 0930 11:30 Venue: Evolve Business Centre, Sunderland Present: Louise Smyth Network Delivery Lead - NESCN Alison
More informationPlan to Improve Working Relationships with General Practitioners Action Plan Approved October 2009
Plan to Improve Working Relationships with General Practitioners Action Plan Approved October 2009 Domain Action Responsibility Timescale Assurance Progress (Feb 10) 1. Communications 1.1 This plan to
More informationImproving the prevention, early detection and management of Acute Kidney Injury (AKI) in Wessex
Improving the prevention, early detection and management of Acute Kidney Injury (AKI) in Wessex The case for change AKI is recognised as a major public health and patient safety concern nationally and
More informationLower urinary tract symptoms - Stakeholder List:
Lower urinary tract symptoms - Stakeholder List: Abbott Laboratories Limited Afiya Trust, The Age Concern England Aintree University Hospitals NHS Foundation Trust Airedale Acute Trust Airedale and Bradford
More informationMinutes 18 July 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager
Quality and Clinical Governance Committee Date Chair Minutes 18 July @ 3.00pm 4.30pm Surrey Heath House, Knoll Road, Camberley, Surrey GU15 3HD Michele Harrison, Quality Manager Members Present Gareth
More informationGREAT WESTERN HOSPITALS NHS FOUNDATION TRUST
The 3T s Formulary Swindon CCG Wiltshire CCG Great Western Hospitals NHS Foundation Trust (In collaboration with Avon and Wiltshire Mental Health Partnership and Oxford Health NHS Foundation Trust Formulary
More informationCamden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly
Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly
More informationAnnual Complaints Report 2017/2018
. Annual Complaints Report 2017/2018 CCG Information Reader Box Document Purpose CCG Website Link Title Author For information www.easterncheshireccg.nhs.uk NHS Eastern Cheshire Clinical Commissioning
More informationQUALITY IMPROVEMENT COMMITTEE
Present: Sheila Dilks (SD) (Chair) Hayley Cavanagh (HC) Sarah Clein (SC) Anne Eccles (AE) Brian Green (BG) Tanya Jefcoate- Malam (TJM) Dr Andy McAlavey (AMcA) Helen McCairn (HMcC) Dr Julia Riley (JR) Pam
More informationTRAINING PROSPECTUS WARRINGTON BOROUGH COUNCIL
TRAINING PROSPECTUS WARRINGTON BOROUGH COUNCIL 1. INTRODUCTION The Town Hall Golden Gates Why Warrington? It is said that Warrington is where the north begins when travelling up the M6 or on the west coast
More informationStatement 2: Patients/carers are offered verbal and written information on VTE prevention as part of the admission process.
THROMBOSIS GROUP Venous thromboembolism (VTE) is a collective term referring to deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is defined by the following ICD-10 codes: I80.0-I80.3, I80.8-I80.9,
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Finance, Performance and Commissioning Committee Report 3. Key Messages: At the end of March 2017 the clinical commissioning
More informationWest Cheshire Children s Trust Executive
West Cheshire Children s Trust Executive Action Note of meeting held on Monday 24 th March 2014 (Room G1, CWaC HQ Building, Chester) In attendance: Stephen Moore (Chair) Sarah Blaylock CWaC Policy Manager
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationLiberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making
Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making Royal Pharmaceutical Society response The Royal Pharmaceutical Society (RPS) is the professional
More informationNORTHWEST PREVENTION & MANAGEMENT OF INPATIENT FALLS AUDIT
PREVENTION & MANAGEMENT OF INPATIENT FALLS AUDIT AINTREE UNIVERSITY HOSPITALS NHS FT AUDIT RESULTS Summary Aintree University Hospital Foundation Trust Acute healthcare Urban population of 330,000 North
More informationGuidelines for the Recognition and Treatment of Acute hypersensitivity reactions including anaphylactic shock in Adult Oncology & Haematology Patients
Guidelines for the Recognition and Treatment of Acute hypersensitivity reactions including anaphylactic shock in Adult Oncology & Haematology Patients Version Three Date of Publication: Version 1 - June
More informationPresent: Dr Stephen Bentley Specialist Doctor Assistant Director Integrated Commissioning Associate Director Health Services Commissioning
Agenda Item No: C DRAFT Minutes of the Meeting of the Governing Body held on Wednesday at 1.30 p.m. in Jubilee Suite, Orford Jubilee Suite, Winwick Road, Warrington Present: In Attendance: Dr Andrew Davies
More informationCRITICAL FOR CARE A Vision for Post Graduate Critical Care Education and Training in Cheshire and Mersey: Designed by Professionals for Professionals
Cheshire and Mersey Critical Care Network CRITICAL FOR CARE A Vision for Post Graduate Critical Care Education and Training in Cheshire and Mersey: Designed by Professionals for Professionals Mary Jordan
More informationThe pathway highlights a clear strategy for managing these patients which includes the following:
James Cook University Hospital Streamlining the pathway for patients identified in surgical pre admission clinics (PAC) with previously undetected atrial fibrillation. Why was this project implemented?
More informationDRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service
DRAFT Service Specification GP-led Urgent Treatment Centre (UTC) Service Executive summary: The Cornwall Sustainability and Transformation Plan known as Shaping our Future will describe a new model of
More informationPrimary Eyecare Mersey Minor Eye Conditions Service. Cataract Services
Primary Eyecare Mersey Minor Eye Conditions Service Cataract Services What is a cataract? It is when the lens of the eye becomes cloudy and difficult to see through. You may find: Things look cloudy or
More informationTo contact us please
Issue 13, June 2015 Newsletter for Care Home staff, General Practitioners and Community Pharmacists The Caring for Care Homes team produced The Medicines Management Checklist in 2010 to provide care homes
More informationImproving Safety Practices Anticoagulation Therapy
Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and
More informationHaving a lower gastrointestinal endoscopy (colonoscopy)
Having a lower gastrointestinal endoscopy (colonoscopy) Patient name Appointment date Arrival time Endoscopy sessions run from 9am to 1pm and 1.30pm to 5pm. Every effort will be made to see you promptly
More informationImplementing bulk prescribing for care home patients
Bulletin 66 May 2014 Community Interest Company Implementing bulk prescribing for care home patients There are many patients in care homes taking medicines when required (prn), and this inevitably presents
More informationNorth Central London Medicines Optimisation Network. Terms of Reference. North Central London Medicines Optimisation Network 1 of 8
North Central London Medicines Optimisation Network Medicines Optimisation Committee Terms of Reference North Central London Medicines Optimisation Network 1 of 8 Document control Date Version Amendments
More informationCroydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement
Shared Care Guideline: Prescribing Agreement Section A: To be completed by the hospital consultant initiating the treatment GP Practice Details: Name: Address: Tel no: Fax no: NHS.net e-mail: Consultant
More informationGP and Lead Clinician, Respiratory MCN (chair) Respiratory Care Facilitator, WL CHCP
LOTHIAN RESPIRATORY MCN CORE GROUP Minutes of the meeting of Wednesday 18 December 2013 in Seminar Room 6, Chancellor s Building, Royal Infirmary of Edinburgh Present Dr Ninian Hewitt Ms Shena Brown Ms
More informationBOARD OF DIRECTORS MEETING 7th March 2018
BOARD OF DIRECTORS MEETING 7th March 2018 Agenda Item TB058/18 Report Title Executive Lead Lead Officer Monthly Safer Staffing Report (January 2018) Sheila Lloyd Director of Nursing Midwifery Therapies
More informationGP and Lead Clinician, Respiratory MCN (chair) Respiratory Care Facilitator, WL CHCP
LOTHIAN RESPIRATORY MCN CORE GROUP Minutes of the meeting of Tuesday, 14 May 2013, 2.00pm to 3.30pm, Seminar Room 3, Chancellor s Building, Royal Infirmary of Edinburgh Present Dr Ninian Hewitt Ms Shena
More information